Investigational ADHD treatment for adults
Part of Mental health clinical trials.
This study tests an investigational medication for adults with attention deficit hyperactivity disorder (ADHD). It aims to see if this new drug helps reduce ADHD symptoms compared to a placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a formal diagnosis of attention deficit hyperactivity disorder (ADHD).
- You need to be in generally good health, and any current medications must be stable for at least 2 months.
- You must have a certain level of ADHD symptoms (measured by a standard scale).
- Your BMI must be between 18 and 35.
- You should not have a history of serious psychiatric conditions like schizophrenia or bipolar disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 4 study looks at how to manage ADHD symptoms in children and teens who also have autism. It may help your child’s care team learn what treatment routines work best in real life settings.
This trial tests an investigational medication for adults with major depressive disorder who are currently taking an antidepressant but still have symptoms. It aims to see if adding this new drug can improve mood better than a placebo.
This trial tests an experimental drug (EB-1020) for children with ADHD. It aims to see if the drug is safe and effective in reducing ADHD symptoms.
This trial tests if the medication Foquest can help treat ADHD symptoms in adults aged 65 and older. It aims to see if it's safe and effective for this age group.
This trial tests if a mixed amphetamine medication helps teenagers with both autism and ADHD who still have significant symptoms, even if they are already on other treatments. It also includes typically developing teens as a comparison group.
This Phase 4 study checks whether certain markers change in the brain/body when children with ADHD take methylphenidate (a stimulant). It also compares these markers with healthy children to better understand ADHD.
Hear when a new Attention Deficit Disorder With Hyperactivity (ADHD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.